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ABSTRACT: Vaccination against classical swine fever (CSF) is an essential measure for its control in
endemic areas, and the Chinese Strain has been used with success in already disease free countries.
Nevertheless the complexity of the factors interacting on the epidemiology and control of CSF, when
the expected success is not reached with the vaccination of premises, doubts always fall on the vaccine
used and the vaccination scheme applied In consecuences, many changes in vaccination scheme by the
breeders are frecuently observed whitout positive influence in CSF control. To clarify the CSF recurrence
in a herd vaccinated by a different scheme as the one recommended in the national control program,
serological samples were taken to different animal groups in three moments. Sample I, to evaluate the
response to the vaccination scheme decided by producers (litters on 5 and 40 days); and samples II and
III, to know its behaviour after the implementation of the scheme recommended by official veterinary
service (litters at weaning, at 33 days). The presence of titres =1:50 in all litters at 3 days of age (Sample
I), indicated that primo-vaccination at 5 days is not correct. The absence of protective titres on 22% of
the animals (9/41), belonging to the groups with clinical cases of the disease, at only 23-30 days from
the second doses, confirmed that the double vaccination scheme at 5 and 40 days was not correct.
Although at 33 days of age a risk of vaccinating in the presence of high titres of passive antibodies
(=1:50) in 65% of the pigs was present (Sampling II), it was verified that at 37 post-vaccination days all
pigs showed high neutralizing antibodies titres (Sampling III). This result, together with the clinical
behaviour and humoral response of pigs on pre- fattening demonstrated that primo-vaccination at 33
days was adequate and contributed to the control of clinical manifestation of the diseases in the herd.
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RESPUESTA HUMORAL A DIFERENTES ESQUEMAS DE VACUNACIÓN CONTRA
PESTE PORCINA CLÁSICA (PPC) APLICADOS SUCESIVAMENTE DURANTE UN
FOCO ACTIVO DE LA ENFERMEDAD
RESUMEN: La vacunación contra la peste porcina clásica (PPC) es una medida esencial para su control
en áreas endémicas, y la cepa china ha sido empleada con éxito en países ya libres de la enfermedad.
No obstante la complejidad de los factores que interactúan en la epidemiología y el control de la PPC,
cuando no se obtiene el éxito esperado con la vacunación de los rebaños, las dudas siempre recaen en el
producto vacunal y su esquema de aplicación. Es así como muchos criadores hacen cambios en los
esquemas de vacunación sin que se observen influencias favorables en el control de la enfermedad. Para
esclarecer la recurrencia de la enfermedad en un rebaño donde se estaba aplicando un esquema de
vacunación diferente al recomendado en el programa de control vigente, se realizaron muestreos
serológicos a diferentes grupos de animales en tres momentos: Muestreo I, para evaluar la respuesta al
esquema de vacunación orientado por los productores (crías a 5 y 40 días); y Muestreo II y III, para
conocer su comportamiento tras la implementación del esquema recomendado por el servicio veterinario
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INTRODUCTION
Vaccination against Classical Swine Fever (CSF)
is an essential measure for its control in areas where
the disease is endemic (1; 2), and vaccination with
the Chinese Strain is recognized by its effectiveness
and contribution to the disease eradication in several
countries (3).
In Cuba, CSF was under control through
vaccination program among other sanitary measures.
There was an epizootic silence for more than 25 years,
until its re-emergency in 1993, due to the unfavourable
economical situation affecting the sanitary stability of
the national swine herd, which in parallel produced an
increase of the backyard breeders with the well-known
breaches  on bio- safety.
Until now, several human and financial resources
have been used without the corresponding success
on the control of the disease.  That is why, the different
situations presented as evidence of the problems
affecting the control of the disease are always
analyzed. Nevertheless, in spite of the complexity of
the factors interacting on the epidemiology of the
disease and its control, when CSF is introduced or re-
emerge on systematically vaccinated herd, doubts falls
always on the vaccine or the applied vaccination
scheme, in a manner that there is always breeders
trying with vaccine schemes different to that
recommended by the sanitary authorities.
In this work, the humoral response to the
vaccination against CSF obtained by an early
immunization scheme in an outbreak of the disease
and also the behaviour after the use of recommended
by the control program in force used in the country
were evaluated.
Therefore, in a CSF re- emerging case where a
vaccination program not adjusted to the indications of
the Prevention and Control National Program for CSF
(4) was applied, the humoral response to the
vaccination schema used was evaluated comparing
with the response obtained after the application of the
scheme legally in force.
MATERIALS AND METHODS
Experimental design
In a herd of 450 sows, previously recovered from a
CSF outbreak, the animals were maintained under
vaccination scheme oriented by the producers
(Chinese Strain; LABIOFAM, S.A) to the litters at 5
and 40 days born, to the sows 4 times a year and
every 6 months to the sires, as part of the measures
for the control of the disease.  In order to clarify the
recurrence of the disease, a serological test was
carried out in the different animal groups (Technological
Sections, S) (Sampling I), and the vaccination sheme
recommended by official veterinary services was
implemented, among another sanitary measures.
Sows and litters at post-weaning time (33 days) were
vaccinated; sires were vaccinated every six month,
as usual.
In Sampling, researches regarding 18 pregnant
sows between 8 and 11 pregnancy  weeks at the final
stage of gestation; two groups of 20 litters each at 3
and 33 days of age; 20 and 21 swine of  4 and 5 pre-
fattenings sections, were carried out.
After vaccination sheme change, for monitoring the
passive immunity of the litters before primovaccination,
a sampling was done (Sampling II) using two groups
of 10 sows, with two piglets each, at 15 and 33 days
post partum, respectively. To evaluate the response
to the new vaccination scheme, another serological
sampling (Sampling III) was done four months later in
six groups of animals (49) in different pre-fattening
oficial (crías al destete, a los 33 días). La presencia de títulos =1:50 en todas las crías a los tres días de
nacidas (Muestreo I), indicaron que no era correcta la primovacunación a los cinco días. También la
ausencia de títulos protectores en el 22 % de los cerdos (9/41), pertenecientes a los grupos con casos
clínicos de la enfermedad, a solo 23-30 días de aplicada la segunda dosis, corroboró que el esquema de
vacunación doble a los 5 y 40 días era incorrecto. Aunque a los 33 días de edad se tuvo el riesgo de
vacunar en presencia de altos títulos de anticuerpos pasivos (=1:50) en el 65 % de los lechones (Muestreo
II), se constató que a los 37 días post-vacunación (DPV) todos los cerdos tenían títulos altos de anticuerpos
neutralizantes (Muestreo III). Este resultado, junto al comportamiento clínico y respuesta humoral
posterior de los cerdos en preceba, demostraron que la primovacunación a los 33 días fue adecuada y
que contribuyó al control de la manifestación clínica de la enfermedad en el rebaño.
(Palabras clave: peste porcina clásica; anticuerpos; vacunación; cerdos; serología; foco)
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and fattening technological sections (S). In all cases,
blood was obtained through vein.
Antibody detection
Peripheral blood samples without anticoagulant
were taken to determine the presence of neutralizing
antibodies against classical swine fever virus (CSFV),
by neutralizing peroxidase linked assay (NPLA).
Assays were done as the technical specification (5)
with PK 15 cells on 96 wells plates and 100 DICT 50 of
Margarita Strain (6). Sera were evaluated at titres of
1:25 and 1:50 (Sampling I and II). At Sampling III, the
humoral response of the young pigs (pre-fattening) at
30 days post-vaccination (PVD) was evaluated at titres
from 1:32 to 1:256; and screening test was carried
out to the remaining samples at 1:50 dilution as a valid
criterion of protection for vaccinated animals (7).
RESULTS AND DISCUSSION
Many questions arise from the introduction or
recurrence of CSF in herds, mainly when producers
try to fulfil the established measures to prevent and
control the disease in endemic areas. When failure
on the control occurs, many doubts falls on the quality
of vaccines and the effectiveness of the application
method, due to the great importance of both aspects.
The national lapinized Chinese strain vaccine,
contains 100 protective infectious doses (pid) per
animal, recommended by the World Organization for
Animal Health (OIE)  and its quality is verified by the
State Control Laboratory.
Neutralizing antibody titres higher than 32 are
accepted as protective after applying the modified life
vaccines (7). As vaccinal antigens are capable to
present themselves to the immune system through
exogenous and endogenous way, they efficiently
activate both humoral and cellular immunity which is
traduced in a good correlation between the antibody
production and Interferon-ã (8; 9).
The presence of titers =1:50 in every litter at 3 days
of age, and the 80% decrease (16/20) at only 28 days
after primo-vaccination, demonstrated that the
vaccinated scheme in use was unsuitable (5 and 40
days of age) (Table1).
The results demonstrated that sows were correctly
vaccinated and transfered adequate antibody levels
to the litters. Thus, if the litters were vaccinated at 5
days of age, the existent high passive antibody titers
would neutralize the vaccinal antigen.
It is generally accepted that passive antibody titers
higher than 32 significantly affect the induction of
protecting immunity through vaccination with modified
live strains, causing vaccine failures (10; 11; 12).
At the same time, it is recognized that in endemic
areas, specially during an active focus of the disease
with a high viral circulation, sows previously vaccinated
received a constant booster (9).This situation is a
problem, because contributes to the increase of titers
which are being transferred passively to the litters,
probably also conducting to vaccinal failures if this is
not taken into account when applying the primo-
vaccination.
The Chinese Strain vaccine is capable of inducing
complete protection if it is applied at the right moment,
when it cannot be interfered with the colostrum
antibodies. Thus, in challenged vaccinated pigs an
inhibition of both humoral and cellular immunity has
been observed, in the same proportion as the higher
passive titers at vaccination; and when it occurs, it is
corroborated that the 50% of pigs eliminates viruses
after challenge (12).
Primo-vaccination in the presence of high passive
antibody titres as the cause of vaccination failures and
the existence of swine apparently healthy eliminating
virus for long periods are considered the main causes
of the increasing of focuses in areas where CSF is
endemic and vaccination is systematic, as it occurred
in Mexico and Thailand during the last years (13; 9).
In the studied herd, an evidence of vaccination
failures has occurred due to the presence of CSF in
pigs from 9 weeks of birth (pre-fattening Section 4 and
5), where the 22% of the sampled animals (9/41) did
not protect titres (=1:50), only at 23 and 30 days after
finishing the two-dose vaccination scheme,
respectively.
These results helped to the producers to support
the proposal to modify the vaccination scheme, starting
to apply primo-vaccination at 33 days, at weaning,
taking advantage for vaccinating the mothers at the
same time.
In Sampling II (Table 2), the two 15 day-pigs with
titres of 1:25 belonged to the same litter, indicating
that the mother could not transferred a good immunity
through its colostrum. Concerning pigs with 33 days
of age, the results also indicated the effect of the
mother, as one of them had her two pigs negative and
other sow had litters with titres of 1:25. These sows
were destined to sanitary slaughter after parturition,
due to their former poor reproductive performance and
as part of the herd sanitation. In general, the low titres
obtained in 7 of the litters could be influenced by the
deficient immunological status of the sows in which
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several factors such as nutritional, management or
infectious causes could be determined.
As it was demonstrated, the 33% (7/20) of the litters
at 33 days of age (Sampling II, Table 1), did not have
protective titres, evidencing the maintaining of a high
infection pressure in the herd, even when applying the
rest of the sanitary measures. However, vaccinating
at that moment was also a risk, due to the presence
of high passive antibody titres (=1:50), in 65% of the
remaining pigs.
The demonstration of high titres at 37 DPV in all
vaccinated 33 days of age pigs (Table 3), together with
the gradual decreasing of disease cases in the herd
in successive months indicated that the decision of
vaccinating at that moment was correct to stop the
outbreak.
As in endemic areas, the natural exposure to
CSFV can occasionally occur; the sows
systematically vaccinated can increase the antibody
titres without clinical signs of the disease, and  the
transfer to their offspring produce interferences on
the induction of an active immune response at the
vaccination moment.
TABLE 1. Serological results in swine vaccinated with two different schemes./ Resultados serológicos en cerdos 
vacunados con dos esquemas diferentes 
 
1 PVD: Post vaccination days                         * Sows vaccinated every 4 months 
2 Vaccinated at 5 days and before receiving the second dose.  
3 Vaccinated with double vaccination scheme, 5 and 40 days of age. 
4 Vaccinated at 33 days of age 
NR: Non-reactive at 1:25 
S: technological sections 
Reactivity NPLA Sampling Animals Category DPV 1 
NR 1:25 <1:50 ?1:50 
I 18 Pregnant sows (8 to 11 pregnancy week) * 1 1  16 
I 20 Litters (3 days)  - - -  20 
I 20 Litters (33 days) 2 28 - 4  16 
I 20 Pre-fattening 
3 
(S 4, 9 weeks) 23 5   15 
I 21 Pre-fattening 
3 
(S 5, 10 weeks) 30 2 2  17 
II 20 Litters (15 days)  - - 2  18 
II 20 Litters  (33 days)  - 5 2  13 
III 9 Pre-fattening 
4 
(S 5, 10 weeks) 37 -  - 9 
III 7 Prefattening  
4 
(S 8, 13 weeks) 58 -  1 6 
III 8 Pre-fattening  
4 
(S 9, 14 weeks) 65 -  1 7 
III 9 Fattening 
4 
(S 6, 20 weeks) 108 -  2 7 
III 8 Fattening
 4 
(S 7, 21 weeks) 115 -  4 4 
III 8 Fattening  
4 
(S 8, 22 weeks) 122 -  1 7 
TABLA 2. Results obtained in litters, in relation to their 
mothers (Sampling II)./ Resultados obtenidos en las 
camadas con relación a sus cerdas madres 
 
* PPD: Post- Partum Days 
Sows 
(15 PPD) with: 
Sows (33 PPD) 
with: NPLA Titer in 
litters Two litters Two litters 
One 
litter 
?1:50 9 5  
1:25 1 1  
NR - 1 3 
Total 10 7 3 
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These findings and others indicating that passive
antibody titres higher than 128 were necessary for
conferring protection against certain low virulence CSF
isolates from Thailand, have motivated the insistence
on the necessity to monitore the immunological status
of the herds since vaccination failed in inducing
protection, particularly in endemic areas where
vaccination was overused and pigs were vaccinated
at very low age (9). Thus even if many factors could
influence on unsuccessful vaccination programs, the
difficulties arising from the vaccination of pigs with
maternal antibodies are considered one of the most
important factor (13; 9).
The high titres observed at 37 days post-
vaccination (PVD) in all pigs vaccinated at 33 days of
age (Table 3), contrasted with the ones in the animals
of similar age ( Section 5, Sampling I),only after 30
days from the biphasic vaccination ( 5 and 40 days),
where the 19 % of the animals did not have protective
titres (Table 1). Similar favourable results were
observed in the following sections on pre-fattening and
fattening, although in Section 7 only the 50% of the
pigs showed protective titres (Sampling III), in which
other processes could influence producing vaccination
failures.
It was also pointed out that for vaccinating pigs after
5 weeks of age developed a higher quantity of
neutralizing antibodies and Interferon- ã producing
specific cells against CSF than the ones vaccinated
at 3 weeks (14), because it was recognized that the
swine immune system was not completely mature until
4 weeks of age (15). Thus, under outbreak conditions
the animals were vaccinated very young with two
doses, and the second dose was applied as a booster
at 30 days, it was recommended to interrupt this
practice as soon as possible (9).
When CSF is introduced in a free country or zone
where vaccination is not applied, it is clear that the
early vaccination of litters can be the solution for the
emergency, until it could be guaranted an adequate
protection of the litters through the vaccination of the
sows. But in endemic areas, with a systematic
vaccination of the herds, in which CSF is not usually
present in litters or adult animals, but in pigs after
weaning on  transition to the fattening, it is evident
that the most important problems are failures in the
consolidation of post-vaccination active immunity.
With the aim to stop the known losses produced
by CSF, producers make mistakes such as the early
vaccination of the litters and the indistinctly
revaccination of any category. The bad consequences
of the wrong use of a vaccine can be harmful as they
do not use it on a control strategy.
Another aspect causing disagreements is the
frequency of vaccinating sows. In this sense, results
referred on a field assay were interesting, the majority
of the vaccinated sows were sero-positive between
2,5 and 3 years after vaccination, and less than half of
the ones vaccinated under ¨ real¨ field conditions were
sero- positive a year later (16).
In practice, special care most be taken on the
vaccination of the breeders. In relation to the place
where the vaccine is applied and the type of needle
used, precaution has to be taken in applying the
injection in the muscle (not in the subcutaneous fat
layer) in which the length of the needle is important.
On big animals, it is recommended to apply the
vaccine in the lateral-cervical region behind the ear
using needle 1-1.5 x 18, with the precaution not to
remove it quickly after applying the product to avoid
the reflux of the liquid (4).
It is considered that the change on the vaccination
scheme, together with the rest of the sanitary
measures strictly applied, decisively contributed  to
the gradual herd recovering, demonstrated by the not-
appearance of new sick animals and the improvement
of the bio-productive indicators during the period
evaluated.
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* PVD: Post-vaccination days 
Reactivity NPLA Animals Category PVD* 
1:32-1:64 1:128-1:256 1?256 
9 Prefattening S 5, 10 weeks 37 1 2 6 
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